Delivery Order HHSO100201300015I-75A50119F33002

Award Date 9/30/19
Potential Completion Date 12/31/21
Potential Value $14M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bloomington, IN 47403, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
This is a $65,806,649.98 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Biofactura Inc. for preclinical and manufacturing development activities. The contract includes cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract was awarded on September 26, 2019 with an ultimate completion date of March 30, 2029. The contract has no...
This is a $918,380,272.80 definitive contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Phlow Corp, a for-profit pharmaceutical manufacturer, to provide U.S.-based advanced manufacturing of COVID-19 essential medicines and responses to future threats. The contract has a 10-year period of performance ending in May 2030 and uses a cost-plus-fixed-fee pricing structure. The award is funded under ASPR's...
This is a $23,109,340.68 cost-plus-fixed-fee delivery order awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company manufacturer, by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the development of a plasma-derived polyclonal antibody-based COVID-19 therapeutic, under the Centers for Innovation in Advanced Development and Manufacturing program. No...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc., a leading contract research and manufacturing organization that specializes in developing gene therapies, vaccines, oncolytics, and immunotherapies. The $18,746,654.00 cost-plus-fixed-fee task order is to support current Good Manufacturing Practice (cGMP) manufacturing of the...
This federal contract award, valued at $1,514.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of COMIRNATY (COVID-19) vaccine vials for individuals aged 12 and up, with a completion date of October 2, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response has awarded a $481,600 firm fixed price delivery order to Glaxosmithkline, LLC for fill/finish and release of one cGMP adjuvant bulk lot under Clinical Line Item Number 0006E. Performance will occur at Glaxosmithkline's North Carolina facilities with a completion date of June 30, 2024. This delivery order was issued under an existing contract vehicle, though details of the overarching...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Cost Plus Fixed Fee Delivery Order contract to Par Sterile Products, LLC, a foreign-owned, for-profit manufacturer of goods, for the Maintaining a State of Warm Base program, also known as FFMN. The contract has a potential value of $1,782,376.00 and a completion date of September 25, 2022. This contract is a Delivery Order under the Fill and Finish Manufacturing Network (FFMN)...
This is a delivery order awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corporation, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The $1,986,163.00 fixed-price order funds Protein Sciences to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support...

This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Catalent Indiana LLC, a contract development and manufacturing organization. The $13,917,423.00 award is for fill and finish manufacturing services to support pandemic preparedness and response efforts under the Fill and Finish Manufacturing Network multiple award indefinite-delivery/indefinite-quantity contract. The contract does not have a set-aside designation. Catalent Indiana LLC has also received subcontract awards from Regeneron Pharmaceuticals Inc. related to storage, fill and finish manufacturing, and regulatory support for Regeneron's REGEN-COV antibody cocktail to treat COVID-19.

Generated 9/10/24, 11:20 AM